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Abstract
Background: Ivermectin (IVM) has been used in Ghana for over two decades for onchocerciasis control. In recent years there
have been reports of persistent microfilaridermias despite multiple treatments. This has necessitated a reexamination of its
microfilaricidal and suppressive effects on reproduction in the adult female Onchocerca volvulus. In an initial study, we
demonstrated the continued potent microfilaricidal effect of IVM. However, we also found communities in which the skin
microfilarial repopulation rates at days 90 and 180 were much higher than expected. In this follow up study we have
investigated the reproductive response of female worms to multiple treatments with IVM.
Methods and Findings: The parasitological responses to IVM in two hundred and sixty-eight microfilaridermic subjects from
nine communities that had received 10 to 19 annual doses of IVM treatment and one pre-study IVM-naı ¨ve community were
followed. Skin snips were taken 364 days after the initial IVM treatment during the study to determine the microfilaria (mf)
recovery rate. Nodules were excised and skin snips taken 90 days following a second study IVM treatment. Nodule and
worm density and the reproductive status of female worms were determined. On the basis of skin mf repopulation and skin
mf recovery rates we defined three categories of response—good, intermediate and poor—and also determined that
approximately 25% of subjects in the study carried adult female worms that responded suboptimally to IVM. Stratification of
the female worms by morphological age and microfilarial content showed that almost 90% of the worms were older or
middle aged and that most of the mf were produced by the middle aged and older worms previously exposed to multiple
treatments with little contribution from young worms derived from ongoing transmission.
Conclusions: The results confirm that in some communities adult female worms were non-responsive or resistant to the
anti-fecundity effects of multiple treatments with IVM. A scheme of the varied responses of the adult female worm to
multiple treatments is proposed.
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Introduction
Ivermectin (Mectizan) has been in operational use for the
control of human onchocerciasis in the former Onchocerciasis
Control Programme in West Africa (OCP) areas since 1987 and is
still the drug of choice for the African Programme for
Onchocerciasis Control (APOC) and the Onchocerciasis Elimi-
nation Programme for the Americas (OEPA). A single dose of
ivermectin rapidly kills skin microfilariae (mf) and inhibits
microfilarial release by adult female worms, possibly because of
paralysis of the lower uterus [1]. These effects result in a rapid
decline in skin microfilarial counts, an accumulation of degener-
ating intra-uterine microfilariae and a long-lasting suppression of
Onchocerca volvulus microfilaridermias [2]. However, the inhibition
of mf release is reversible by six months resulting in the
reappearance of microfilariae in the skin (repopulation) and after
a further six months a restitution of a proportion of the initial load
(recovery) [2]. A proportion of ivermectin exposed female worms
do not resume reproductive activity even after one year [1] and
this can persist for up to 18 months after treatment [3]. The
prolonged microfilarial suppressant effect of ivermectin has
beneficial effects on morbidity and on parasite transmission.
Several studies [1,4,5,6,7,8] have demonstrated that multiple
treatments with ivermectin have marked suppressive effects on
embryogenesis consistent with some cumulative effect of ivermec-
tin treatments on microfilarial production. Quantitative estimates
have ranged from an irreversible decline in microfilarial
production of ,30% after five annual treatments [9], a reduction
in the productivity index of 90% or more after 10 six-monthly
doses over 6 years [10], to arrest of development at the single cell
stage after four or five six-monthly doses [11]. Recently, the
cumulative effect of ivermectin on microfilarial production by O.
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with a number of necessary assumptions, of data generated in
three Guatemalan villages that were subjected to five 6-monthly
treatments. The conclusions from this study are, however, not
consistent with data generated previously in Africa. Despite the
varying dosage schemes, methodologies, criteria of assessment and
interpretation of results that have been used, it is evident that the
presence of a significant proportion of adult female worms
producing viable microfilariae 3 to 6 months after treatment,
following multiple doses of IVM, is inconsistent with a normal
response. A sub-optimal response is manifested as higher than
expected skin microfilaria counts at various time points post
treatment. Awadzi and others [13] have proposed that for effective
response of O. volvulus to IVM, the mf load in a patient one year
after the last IVM treatment should not be .10 mf/snip following
nine or more years of annual treatments.
Despite previous African experience there are current reports of
persistent, moderately high microfilaridermias after repeated
ivermectin treatments [13,14,15]. These reports suggest that a
population of adult female worms may have been selected that
responds poorly to ivermectin. The development of resistance to
ivermectin and other macrocyclic lactone anthelmintics has
become widespread and is increasing in nematode parasites of
sheep, goats and cattle, including Haemonchus contortus and Cooperia
onchophora [16,17,18,19]. With the distribution of more than 400
million doses of ivermectin as the only drug for mass onchocer-
ciasis control in Africa [20] and with some communities having
received more than 19 annual doses, it would not be surprising
that the genetic selection [21,22,23,24] observed in O. volvulus with
IVM treatment was indicative of the development of ivermectin
resistance in this parasite.
We have previously reported moderately high early repopula-
tion of skin with microfilariae by some populations of adult O.
volvulus [15]. Following this report, we have reassessed the
differences between O. volvulus populations showing poor responses
and those showing good responses to ivermectin using various
indicators of skin microfilarial repopulation, nodule and worm
viability, adult worm densities, and female worm fertility in the
original 10 endemic communities.
Methods
Study Design
This was a randomized, open 21 month longitudinal study
involving two annual ivermectin treatments, serial skin snipping
and nodulectomies in the communities under a study that was
carried out between October, 2004 and June, 2006. Skin
microfilarial profiles were assessed in onchocerciasis affected
patients at various time-points pre- and post-treatment to
determine skin mf repopulation and, at one year post treatment,
the microfilaria recovery rates. At the end of the study (90 days
after a second annual treatment during the study), nodules
containing adult Onchocerca volvulus were surgically removed and
digested to extract adult worms. Embryogrammes were construct-
ed to assess the reproductive status of the adult female worms. A
summary of the study design and conduct is shown in Figure 1.
Study Population and Area, Subject Eligibility and
Selection
The study was carried out in 10 onchocerciasis endemic
communities located in three Districts in Ghana; Kintampo and
Atebubu Districts in the Brong-Ahafo Region, and Gonja East
District in the Northern Region. The criteria for selection of the
communities have been detailed previously [15] and for the 9
communities that had received multiple treatments include: good
written documentation on annual community treatment coverage,
good community and individual treatment history, at least one
survey over the previous 6 yrs (prevalence, community microfi-
larial load or both), average treatment coverage $50% in the
previous 5 years, uninterrupted annual treatment over the
previous 6 years and ivermectin treatment within the previous
10–12 months. Additionally, communities had to be accessible by
road throughout the entire study period, especially during the
period for nodulectomies. One community was ivermectin-naı ¨ve
prestudy.
Ethical approval for the study was obtained from the
Institutional Review Board of Noguchi Memorial Institute for
Medical Research, Ghana and the Ethical Review Board of
McGill University, Canada. The informed consent procedure
involved a durbar (meeting with the chief, elders and the entire
community) with the study population at which the study design,
investigative procedures and the risks and benefits of participation
were outlined by the principal investigator in English and in the
local language through an interpreter. Unlimited time was allowed
for questions and explanations. After the durbar individuals who
were interested in participation met with the investigator and
interpreter individually and the contents of the consent form were
explained in detail. After further questions and explanations, each
subject signed or thumb-printed an informed consent form that
testified to the fact that they had been told the details of the study,
any questions they had asked had been answered to their
satisfaction and that they freely consented to participate in the
study.
Investigative Procedures
Subjects were aged between 18–65 years, had lived in the
communities for at least ten years and, with the exception of the
prestudy ivermectin-naı ¨ve, had received between 10 and 19
annual doses of IVM confirmed by interviews of participants and
community ivermectin distributors, and examination of written
Author Summary
Onchocerciasis, commonly known as river blindness, is
caused by the filarial nematode Onchocerca volvulus and is
transmitted by a blackfly vector. Over 37 million people are
thought to be infected, with over 90 million at risk.
Infection predominantly occurs in sub-Saharan Africa. Foci
also exist in the Arabian Peninsula and Central and South
America. Ivermectin, the sole pharmaceutical available for
mass chemotherapy, has been used on a community basis
for annual or semi-annual treatment since 1987. Multiple
treatments with ivermectin kill the microfilariae that are
responsible for the pathology of onchocerciasis. More
importantly, ivermectin suppresses the reproductive activ-
ity of the adult female worms, thus delaying or preventing
the repopulation of the skin with new microfilariae and
thereby reducing transmission. This study extends earlier
reports of sub-optimal responses to ivermectin by
examining repopulation levels of microfilaria one year
after treatment, worm burdens per nodule, the age
structure of adult female worms recovered from nodules,
and the reproductive status of adult female worms 90 days
after ivermectin treatment. In some communities which
have shown a pattern of sub-optimal response to
treatment, the data is consistent with an emergence of
ivermectin non response or resistance manifested by a loss
of the effect of ivermectin on the suppression of parasite
reproduction.
Ivermectin Suboptimal Response in O. volvulus
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the beginning of the study.
All subjects were examined in detail for Onchocerca nodules
and the locations of the nodules were recorded on anatomical
diagrams. One year after the last ivermectin treatment (364 days),
one skin snip was taken from each iliac crest using a 2 mm Holth-
type corneo-scleral punch, by the same member of the study team,
who was experienced with conducting skin snips, to maintain
consistency. A second annual ivermectin treatment was then given
during the study, as part of Ghana Onchocerciasis Control
Program, to all subjects at 150mg/kg body weight. The final skin
snips were then taken by the same operator only from subjects who
were nodulectomised 90 days after the second IVM treatment.
Skin snips were placed in 96-well microtitre plates containing a
few drops of physiological saline solution, incubated for 24 hours
and microfilariae that had emerged were counted using a
dissecting microscope. The average of the microfilarial counts
from the two sites was taken as the intensity of infection for each
subject expressed as microfilariae/snip.
Nodulectomies were performed 90 days following the second
ivermectin treatment, i.e. day 455 after the first study treatment.
Using local anesthesia, all palpable Onchocerca nodules were
aseptically excised from 140 patients from the 10 endemic
communities. Nodules were stored in liquid nitrogen until ready
for digestion. Nodules were dressed free of extraneous tissue and
placed in 50 ml tubes containing 10 ml of 0.5% collagenase (in
sterile medium 199 solution) for digestion at 37uC in a shaking
water bath for 10–24 hours. Adult worms were harvested after
washing with sterile normal saline solution, and under a dissecting
microscope, the viability and morphological age of worms at the
time of nodulectomy were scored and intact/viable female worms
prepared for embryogramme analysis. Worms were classified as
alive prior to nodulectomy based on intact internal morphology,
motility of the worms, and the condition of the uterine
musculature Broken or ruptured worms were not examined for
embryogrammes. The age of the worms was estimated based on
the morphology, including the color and size of the female worms,
the prominence of cuticular ridges and the degree of inclusions
[10,11,25]. In addition to the above criteria, small and transparent
worms were scored as young, opaque and yellowish as middle
aged, and large and brown as older [25,26]. Each intact female
worm was cut into small pieces, two millilitres of fresh sterile
medium 199 was added and worms homogenized using a
toughened glass test tube mortar and pestle. By turning the pestle
gently, the embryonic stages were squeezed out of the pieces of
worms and embryogrammes constructed [27]. The homogenate
was transferred to a Fuchs-Rosenthal counting chamber and all
embryonic stages assessed as described previously [26,27].
Quantitative assessment of normal and abnormal forms of each
embryonic stage up to stretched microfilariae was done to
determine the reproductive status and microfilarial content of
each individual female worm [28].
Data Management and Statistical Analysis
After data verification, the mean microfilarial density (mf/snip)
at each time point and the density as a percentage of the initial
count were determined for each community. The number of
subjects in each community whose skin mf densities were greater
than, the same as, or less than the initial density, or who were skin
snip negative, was defined, as well as the number of subjects with
greater than 10 mf/snip at day 364. Based on skin mf
repopulation (early reappearance of microfilariae in the skin at
day 90 and/or day 180 post-IVM treatment determined in the
initial study), the mf recovery rate (skin mf density, at day 364, as a
Figure 1. Study design. Design for the entire study, showing time points used for examination of various parameters and the study populations at
each phase of the study.
doi:10.1371/journal.pntd.0000998.g001
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of subjects with .10 mf/snip at day 364, communities were
reclassified into four response categories (good, intermediate, poor,
and the pre study ivermectin-naı ¨ve that was used as the
comparator group). The intermediate response category shared
some of the response characteristics of the poor response category,
but not all of the characteristics. The nodule data for the
communities in each response category were pooled separately
and these pooled data sets were used for the analysis of the findings
in the embryogrammes.
Comparisons of microfilarial densities, mf recovery at day 364
and mf repopulation at day 455 (90 days after the second study
IVM treatment) between the 10 communities were carried out on
log transformed data using the Kruskal-Wallis non-parametric test
and pair-wise comparisons by the non-parametric Mann-Whitney
test. Comparison between the 10 communities in terms of nodule
characteristics and worm density and between the IVM response
categories regarding prevalence, reproductive activity of adult
female worms and embryogramme analysis were carried out using
the Chi-square test or Fisher’s exact test where appropriate.
Differences were considered as significant at p, 0.05.
Results
Two hundred and sixty eight of the 301 microfilaridermic
subjects from the 10 communities who had fully participated in the
previous phase of the study [15] were available and agreed to
continue in the follow up study. The results for pretreatment and
microfilaria assessment up to day 180 have already been reported
[15]. In that report, the microfilariae in all communities responded
readily to ivermectin with reductions of 99.3 to 100% being
achieved at day 30. However, we found that while in five of the
nine communities that had received multiple doses of ivermectin
(Baaya, Beposo, Senyase, Hiampe, and Asubende) and in the
ivermectin naı ¨ve community (Begbomdo) the repopulation rate
was as expected and the response was classified as good, in four
multi dosed communities (Kyingakrom, New Longoro, Jagben-
bendo and Wiae) individual hosts had higher than expected skin
mf counts and the response was classified as poor.
The skin microfilarial indicators that were used in this study to
indirectly assess the reproductive capacity of the adult female
worms were the microfilaria recovery rate (% of pre-treatment
level at day 364 post IVM treatment), the distribution pattern of
mf recovery rates of individuals in each community, the number of
subjects with .10 mf/s at day 364 across the communities and the
mf repopulation 90 days after the second IVM treatment during
the study (day 455) in the 140 subjects that participated in the
nodulectomies.
The mf recovery rate for the various communities is
summarized in Table 1. This shows that the microfilaria recovery
rate was less than 80% in four of the five multidosed communities
previously classified as good responders; the exception was
Asubende which had a recovery rate of 103.8%. Three of the
four communities previously classified as poor responders, had
microfilaria recovery rates of more than 110%; the exception was
Wiae with 99.1%.
We compared mf skin recovery rate at day 364 post IVM
treatment (Table 1) between all the 10 communities. Pair-wise
comparisons showed that at day 364 there were no differences in
mf skin recovery between the four multi-dosed communities
(Senyase, Beposo, Hiampe, Baaya). However, Begbomdo, the pre-
study IVM naı ¨ve community, had significantly lower (p , 0.05) mf
recovery rate than the four communities. These five communities
had significantly lower mf recovery than Kyingakrom, Jagben-
bendo and New Longoro (p , 0.01) and Wiae and Asubende (p ,
0.05).
The distribution pattern of mf recovery rates of individuals in
the communities is summarized in Table 2. The good ivermectin
response communities had 0–6% of subjects with an mf recovery
rate of more than 100% of pretreatment counts compared with
40.3%–51.9% of the subjects in the poor ivermectin response
communities. Between these two groups were Asubende (33.3%)
Table 1. Densities of O. volvulus microfilaria before, and at 364 days after treatment, in each community.
Community No. of treatments
No. of subjects examined
on day -7 N = 268 Microfilaria/snip at
Day -7 Day 364 post-treatment
Density % of day -7 * (recovery rate)
Senyase 18 10 1.69 1.21 71.6
Beposo 18 10 2.24 1.62 72.3
Hiampe 17 17 3.03 2.37 78.2
Baaya 18 20 1.38 0.91 65.9
Asubende 19 12 2.40 2.49 103.8{
Wiae 10 22 3.42 3.39 99.1{
Kyingakrom 17 27 6.40 7.41 115.8{
New Longoro 17 62 5.73 6.32 110.3{
Jagbenbendo 12 51 8.17 9.22 112.9{
Begbemdo" 1 37 30.74 12.89 41.91
Geometric mean densities (mf/skin snip) in the ten Ghanaian communities participating in the study.
*Data for % of day -7 are based on the subjects that participated at all sampling times up to day 364.
{p,0.05 when compared to the good responders.
{p, 0.01 when compared with good responders or prestudy IVM-naı ¨ve.
1p,0.05 when compared to good responders. Good responders = Senyase, Beposo, Hiampe, Baaya. Intermediate responders = Wiae, Asubende. Poor responders =
Kyingakrom, New Longoro and Jagbenbendo.
"Ivermectin naı ¨ve at study start.
doi:10.1371/journal.pntd.0000998.t001
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ties, between 55–80% of the subjects had reductions in
microfilarial counts, with 12–20% being amicrofilaridermic one
year after treatment, while in the poor response communities only
26–32% of subjects had reductions and very few to zero. When the
three variables (proportion of individuals having greater than
pretreatment mf densities, same as pre-treatment mf densities and
less than pre-treatment densities) were compared together between
the 10 communities, Kyingakrom, New Longoro and Jagbene-
bendo were significantly higher (p,0.01) than five communities
(Senyase, Beposo, Baaya, Hiampe and Begbomdo). Also Wiae and
Asubende were higher than the four good responding communi-
ties and the naı ¨ve community, but this was not significant.
A further comparison examined the number of subjects with
.10 mf/s at day 364 across the communities (Table 2). There
were 3/57 (5.3%) for Baaya, Beposo, Senyase, Hiampe, the good
responding communities 7/34 (20.7%) for Asubende and Wiae
and 54/140 (38.6%) for Kyingakrom, New Longoro and
Jagbenebendo, the poor response communities. The pre-study
IVM-naı ¨ve community, which at day 364 post the first treatment
during the study had only received a single IVM treatment, had
26/37 (70.3%) subjects with .10 mf/s. The difference between
the good response and Asubende-Wiae communities was not
significant (p=0.197). However the proportion of subjects with
.10 mf/s in the good response communities was significantly
lower than in the poor response and the IVM-naive communities
(p,0.0001). Asubende and Wiae communities were lower than the
poor response (p,0.05) and pre-study IVM-naı ¨ve (p,0.0001)
communities. Across all multi-dosed communities, 27.7% (64/231)
of the subjects had .10 mf/s at day 364 and, given the IVM
treatment history, would satisfy the field definition of suboptimal
responders [13]. Though this does not differ significantly from
25.5% (59/231) of the multi-dosed subjects who had .10 mf/s at
the beginning of the study (Table 2), the good response
communities had a significant reduction in the proportion of
subjects who had .10 mf/s from 10.5% (6/57) at day -7 to 5.3%
(3/57) at day 364. For the Asubende-Wiae communities, there
were no changes, but the poor response communities showed a
slight increase in the proportion of subjects who had .10 mf/s,
from 32.9% (46/140) at day -7 to 38.6% (54/140) at day 364 and
those who had .20 mf/s from 15.7% (22/140) to 24.3% (34/
140).
The determination of the skin mf repopulation 90 days after the
second IVM treatment during the study (day 455) on the 140
subjects that participated in the nodulectomies is summarized in
Table 3. The overall result was similar to that reported for the day
90 mf repopulation observed in the same group of individuals
from the ten communities in the first phase of the study (15). We
observed no skin mf repopulation in the four good response
communities but a small repopulation (2.9% of pretreatment
count) in the prestudy naı ¨ve community. In each of the three poor
response communities the level of skin mf repopulation was greater
after the second study treatment (day 455) than after the first study
treatment (day 90), but the differences were not significant.
When the results of the indices of skin repopulation by mf are
taken together they show a gradation of response to multiple doses
of ivermectin that permits the re-classification of the responses as
good (Senyase, Beposo, Hiampe and Baaya), intermediate
(Asubende and Wiae), and poor (Kyingakrom, New Longoro
and Jagbenbendo). The response to ivermectin in the previously
treatment naı ¨ve community (Begbomdo) was also good based on
mf repopulation levels one year after treatment as a proportion of
pretreatment mf levels.
Nodulectomies were carried out on a total of 140 patients from
the ten communities who agreed to participate in the procedure.
Two hundred and ninety three nodules were removed, giving an
average of 2.1 nodules per subject. In order to better quantify the
nodule characteristics and the embryogramme findings, the data
were pooled separately for communities labeled as good, poor and
intermediate responders on the basis of skin microfilaria
Table 2. Distribution pattern in each community of microfilarial densities one year after ivermectin treatment.
Community
Total No. of
subjects
% (No.) of subjects
with day -7 mf
density .10 mf/s % (No.) of subjects with day 364 mf density:
. 100% of pre-
treatment
The same as pre-
treatment (100%)
Less than pre-
treatment mf
density (0-99%)
Reduced to
zero (0%) . 10 mf/s
Senyase 10 10 (1) 0 20.0 (2) 80.0 (8) 20.0 (2) 0
Beposo 10 10 (1) 0 20.0 (2) 80.0 (8) 20.0 (2) 0
Hiampe 17 17.6 (3) 5.9 (1) 23.5 (4) 70.6 (12) 11.8 (2) 11.8 (2)
Baaya 20 5 (1) 5.0 (1) 35.0 (7) 55.0 (11) 20.0 (4) 5(1)
Asubende 12 16.7 (2) 33.3 (4) n/s 16.7 (2) 50.0 (6) 16.7 (2) 16.7 (2)
Wiae 22 22.7 (5)
3 27.3 (6) n/s 27.3 (6) 45.5 (10) 13.6 (3) 22.7 (5)
4 n/s
Kyingakrom 27 40.7 (11)
6 51.9 (14) 1 22.2 (6) 25.9 (7) 3.7 (1) 48.1 (13)
10 1
New Longoro 62 25.8 (16)
7 40.3 (25) 1 24.2 (15) 32.3 (20) 3.2 (2) 30.6 (19)
10 1
Jagbenbendo 51 37.3 (19)
9 43.1 (22) 1 25.5 (13) 31.4 (16) 3.9 (2) 43.1 (22)
14 1
Begbomdo" 37 81.1 (30)
29 2.7 (1) 0 97.3 (36) 2.7 (1) 70.3 (26)
13 1
Three variables, proportion of individuals having (a) greater than pretreatment mf density, (b) same as pre-treatment mf density, and (c) less than pre-treatment mf
density, were compared in the 10 communities. Kyingakrom, New Longoro and Jagbenbendo (poor responding communities) were significantly higher (1 p,0.01) than
the five communities (Senyase, Beposo, Baaya, Hiampe and Begbomdo) that responded well to IVM treatment. The three poor responding communities were also
higher than Wiae and Asubende (intermediate response communities) but the differences were not significant.
"Ivermectin naı ¨ve at start of study. n/s = not significantly different from good responders. The superscript in the table e.g., (5)
10, represents the number of subjects that
had .20 mf/s.
doi:10.1371/journal.pntd.0000998.t002
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distribution of adult worm populations are shown in Table 4.
Overall, 100 out of 140 subjects (71.4%) had nodules containing at
least one viable worm. The features compared were the number of
subjects with nodules containing viable worms, number of nodules
with viable worms and the average number of male and female
worms per nodule. The prestudy ivermectin naive (Begbomdo),
and the poor response communities were significantly higher (p ,
0.0003) than the good response communities in terms of nodules
with viable worms and the average number of male and female
worms per nodule as well as the number of subjects with nodules
containing viable worms (p , 0.01). The intermediate response
communities were significantly higher (p ,0.002) than the good
response communities only in the average number of male and
female worms per nodule.
The age structure and the state of reproductive activity of adult
female worm populations in endemic communities give important
information on parasite transmission and the contribution of each
parasite age group to the repopulation of the skin with
microfilariae after IVM treatment. The adult female worms were
grouped into older, middle aged and young worms as described
previously and are presented by response category in Tables 5A
and B. In all three categories of response to multiple doses of
ivermectin at least half of the worms were older (52–78%) and
approximately one quarter were middle aged (22–30%). The
proportion of young worms was only 5.1% and 8.1% in the poor
Table 3. Densities and microfilaria repopulation rates after first (day 90) and second ivermectin treatments (day 455).
Community
No. of treatments
at study end
No. of subjects
nodulectomized and
skin snipped day 455
N=140 Microfilaria*/snip at
day -7
Day 90
mf/s (% day -7) Day 364
Day 455
mf/s (% day 364)
Senyase 18 8 1.9 0 (0) 1.3 0 (0)
Beposo 18 5 2.4 0 (0) 1.7 0 (0)
Hiampe 17 7 3.3 0.06 (0.02) 2.2 0 (0)
Baaya 18 6 1.9 0 (0) 1.2 0 (0)
Asubende 19 5 3.2 0 (0) 3.38 0.08 (0.02)
Wiae 10 10 4.1 0.28 (6.8) 4.0 0.2 (5.0)
Kyingakrom 17 20 7.9 1.7 (21.5) { 9.1 2.1 (23.1) {
New Longoro 17 20 7.2 0.63 (8.8) { 8.1 0.99 (12.2) {
Jagbenbendo 12 39 8.2 0.94 (11.5) { 9.16 1.1 (12.0) {
Begbemdo " 2 20 44.2 1.4 (3.2) 17.3 0.5 (2.9)
Geometric mean densities (mf/skin snip) of O. volvulus microfilaria and repopulation rates observed at day 90 following the first study IVM treatment (day 90) and
second IVM treatment (day 455) in the 10 onchocerciasis endemic communities studied in Ghana.
*All data are based only on the subjects that were nodulectomized. At days 90 after the first study treatment and day 90 after the second study IVM treatment (i.e., day
455), there were no differences in skin mf repopulation (mf count as a % of pre-treatment) between five communities (Senyase, Beposo, Hiampe, Baaya and Begbomdo
– good response or naive communities). However, three communities (New Longoro, Jagbenbendo and Kyingakrom) had significantly higher ({ p, 0.05) skin mf
repopulation rates (%) than the good response communities.
" Previously naı ¨ve had received two study treatments.
doi:10.1371/journal.pntd.0000998.t003
Table 4. O. volvulus nodule characteristics and worm densities in the IVM response/treatment categories.
Response/
treatment
categories
IVM
treatment
history
No. of
subjects
nodulectomised
No. of
nodules
removed
No. (%) of
subjects with
nodules
containing
viable worms
No. (%) of
nodules with
viable worms
No. of
male
worms
No. of
female
worms
Average No.
of females
per nodule
Average No.
of males
per nodule
Begbomdo" 2 20 46 19 (95.0){ 42 (91.3)1 68 104 2.261 1.481
Good 18–19 26 51 7 (26.9) 12 (23.5) 8 18 0.35 0.16
Intermediate 11–20 15 29 10 (66.6) 16 (55.2) 19 36 1.24* 0.66*
Poor 13–18 79 167 64 (81.0){ 130 (77.8)1 180 258 1.541 1.081
Total 140 293 100 200 275 416 1.42 0.94
The number of subjects with nodules containing viable worms, number of nodules with viable worms, and average number of males and females per nodule were
compared between the different IVM response categories (see Table 2 for allocation of communities to response categories) and the IVM naı ¨ve community. Begbomdo
and poor response communities were significantly higher (1 p , 0.0003) than the good response communities in terms of number of nodules with viable worms and
average number of male and female worms per nodule, as well as the number of subjects containing viable worms ({ p , 0.01). The intermediate response
communities were significantly higher (* p , 0.002) than the good response communities in the average number of male and female worms per nodule.
" Ivermectin naı ¨ve at start of study.
doi:10.1371/journal.pntd.0000998.t004
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no young worms found in the good response category. This
proportional distribution by age (52–78% for the older worms and
22–30% for the middle aged worms) was similar in all response
categories except the prestudy ivermectin naı ¨ve that had a
significantly higher proportion of young worms (21.2%; p,
0.002) than all multidosed response categories (0–8%). When all
the worms were pooled and compared by age group there were
significantly more older (65.4%) than middle aged (25.5%;
p=0.002) and young worms (9.1%; p,0.0001), and more middle
aged worms than young worms (p,0.0001) (Table 5).
An examination of the live stretched mf production by the female
worms showed clear differences between the 3 response groups. In
the good response category, none of the worms examined was
producing mf. In the intermediate response category 5% of the old
worms and 10% of the middle aged worms were producing mf but
none of the young worms. In the poor response category 15.1% of
the old worms, 22.2% of the middle aged worms and only 0.8% of
the young worms (1 worm) were producing mf. Overall, 12.2% of
the olderworms, 17.2%of the middle aged wormsand only 1.1% of
the young worms were producing mf (Table 6). The differences
between the older and middle aged worms combined and the young
worms were highly significant (p,0.0001) but not that between the
older and middle aged worms.
In order to more precisely quantify the contribution of the
various age groups of adult worms to the skin microfilariae, the
various age categories were pooled across all response groups and
the mean production of stretched microfilariae calculated. The
results are summarized in Table 7. The mean of the production of
total (live and degenerate) stretched microfilariae/female worm
was significantly higher in the middle aged worms as compared to
the young worms (p=0.039), but the older worms were not
significantly different from the young worms (p=0.21). The
middle aged worm production of live stretched microfilariae/
female worm was higher than those of the older (p=0.042) and the
young worms (p=0.033). There was no significant difference
between the numbers of live stretched microfilariae in the young
worms compared with the older worms.
Discussion
In communities where ivermectin is distributed annually as the
sole measure of onchocerciasis control, the interpretation of skin
microfilarial counts over time is governed by proof of regular
consumption of a minimum number of doses, the microfilaricidal
response, the sensitivity of the adult female worms to the
suppression of embryo production, the effects of ivermectin on
microfilarial release and the confounding effect of new microfi-
larial production by young worms derived from reinfection from
local or imported sources. Comparison is then made with
historical data that define microfilaricidal activity (usually
determined at day 30), repopulation (determined at days 90 and
Table 5. Age structure of all female O. volvulus worms sampled in IVM response/treatment categories.
Community
response/treatment
category
No. of years
of IVM
treatment
% (No.)
older female
worms
% (No.)
middle aged
female worms
% (No.)
young female
worms
Total number
of female worms
Begbomdo " 2 51.9 (54) 26.9 (28) 21.2 (22)1 104
Good 18–19 77.8 (14) 22.2 (4) 0 18
Intermediate 11–20 62.2 (23) 29.7 (11) 8.1 (3) 37
Poor 13–18 70.4 (181) 24.5 (63) 5.1 (13) 257
Total - 65.4 (272) 25.5 (106) 38 (9.1) 416
The IVM naı ¨ve community had significantly higher numbers of young worms (1 p, 0.002) than each of the IVM community response categories. The worm age
distribution was not significantly different between the good, intermediate and poor response categories.
" Begbomdo was IVM naı ¨ve at the start of the study.
doi:10.1371/journal.pntd.0000998.t005
Table 6. Prevalence and reproductive activity of young, middle-aged and older female worms in the response/treatment
categories.
Response/treatment
category
No. female worms
Embryogrammed
No. (%) older
female worms
No. (%) middle aged
female worms
No. (%) young female
Worms
Total
Producing
live stretched mf Total
Producing
live stretched mf Total
Producing
live stretched mf
Begbomdo" 20 9 (45.0) 2 (10) 6 (30.0) 1 (5) 5 (25.0) 1 (5)
Good 14 10 (71.4) 0 4 (28.6) 0 0 0
Intermediate 20 10 (50.0) 1 (5) 7 (35.0) 2 (10) 3 (15.0) 0
Poor 126 66 (52.4) 19 (15.1) 48 (38.1) 28 (22.2){ 12 (9.5) 1 (0.8)
Total 180 95 (52.8) 22 (12.2) 65 (36.7) 31 (17.2) { 20 (11.1) 2 (1.1)
In each IVM response category, the proportion of female worms in each age group, producing intra-uterine live stretched mf, were compared. In the poor response
communities, the middle aged worms had a significantly higher ({ p,0.05) proportion of female worms producing intra-uterine live stretched mf than the older and
young worms. Pooling all response groups together, the middle aged worms had significantly higher ({ p,0.03) proportions of female worms producing intra-uterine
live stretched mf than the older and young worms.
" Begbomdo was naı ¨ve at the start of the study and had received two study treatments by time of nodulectomy.
doi:10.1371/journal.pntd.0000998.t006
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best obtained from embryogrammes examined at defined intervals
after drug administration. In our previous study [15] extraordinary
measures were taken to ensure that the number of treatments
allotted to each member of the study cohort was plausible. The
sensitivity of microfilariae in all communities was documented as
was the abnormal repopulation rates in some communities. This
follow up study sought further evidence of deviations from
expected skin mf counts as manifested by mf recovery rates, adult
worm status as defined by nodule and worm viability and adult
worm densities, and provided quantitative estimates of adult
female worm distribution and microfilarial production for various
worm age groups in the original 10 endemic communities. The
microfilaria recovery rates are good indicators for the responses of
O. volvulus to repeated rounds of IVM treatment because a premise
of the control programs is that skin mf counts will progressively
decrease year after year with repeated ivermectin treatment when
coverage is good. Thus unexpected recovery rates act as a stimulus
to the investigation of the cause of persistent microfilaidermia.
Apart from the community recovery rate, the pattern of
recovery in individuals in each community and the number of
subjects with .10 mf/s at day 364 across the communities were
examined. Our results showed that day 364 post treatment skin
microfilaria levels of good response communities, including the
IVM-naı ¨ve community, were below pre-treatment levels, while the
poor response communities were above pre-treatment counts, with
the intermediate response communities showing mf densities
around pretreatment levels.
Studies have shown that irrespective of the initial levels of pre-
treatment microfilarial load, repeated annual treatment with IVM
for five years or more results in reduction of microfilarial loads to a
mean microfilaria density of less than 10 mf/s one year after the
fourth or fifth treatment [9,29,30]. The classical observation is the
study by Alley and others [29] who, using skin snip methodology
similar to that employed in this study, consistently followed up
more than 260 subjects every year after each treatment for five
years. They observed a drastic reduction in the mean microfilaria
counts from .90 mf/s to ,8 mf/s. Our results for the good
response communities are consistent with these reported findings.
In contrast, the poor response communities had mean mf counts of
.10 mf/s to as high as 16.54 mf/s. Furthermore, considering the
distribution of microfilarial loads of individual subjects in each
community (Table 2) we observed significantly higher proportions
(30–48%) of subjects in poor response communities having
.10 mf/s as compared to 16–23% in the intermediate response
communities and 0–12% in the good responding communities
despite repeated ivermectin treatments over more than 10 years.
Awadzi and others [13] defined sub-optimal responders as
individuals who still had at least 10 mf/snip after nine or more
treatments with ivermectin. It should be noted that even in two of
the good response communities we observed that one or two
individuals had mf loads slightly above 10 mf/s and we believe
that even in the good responding communities there may be some
parasites in a few individuals showing a poor response to IVM.
The use of the .10 mfs/snip criterion in assessing recovery rates is
particularly useful as it is independent of initial mf densities and of
percentage change in initial densities. Additional skin snip data
obtained 90 days (day 455) after a second dose of IVM treatment
during the study, confirmed the earlier observation of rapid skin
mf repopulation in the poor response communities.
The skin snip data and their analysis permit the conclusion that
a higher than expected return of mf to the skin occurred in some
communities. The explanation for this finding is that either the
adult female worms have become unresponsive or resistant to the
suppressive effects of multiple doses of IVM or that new infections
from ongoing transmission could account for the higher than
expected rate of repopulation of the skin with microfilariae. This
latter possibility was statistically analyzed [31] and the conclusion
was reached that the patterns in the communities showing sub-
optimal responses could not be explained by new infections.
Furthermore, the distinction between the higher than expected
microfilarial repopulation rates due to new infections or due to
resistance of the adult worms to the effects of ivermectin on
reproduction can also be made on the basis of the examination of
the age distribution and embryogrammes of the adult worms. On
the basis of the age distribution of the adult female worms, the
embryogrammes and the statistical analysis [31], the only
explanation for the rapid repopulation rates seen in the poor
response communities is that individual worms exist in these
communities which do not respond as expected to ivermectin.
Repeated IVM treatment has marked effects on nodule
numbers, morphology and composition, on adult female worm
fertility and a less marked effect on adult worm vitality.
Additionally, a reduction in transmission results in a decrease in
new infections [3,5]. Klager and others [11] reported a marked
tendency towards smaller nodules and fewer live females per
nodule with increasing length of exposure to ivermectin. They also
showed that the geometric mean number of worms per nodule and
total live female and male worms per nodule were significantly
reduced after 10 doses of IVM. For our study, all treated
communities had received at least ten years of annual IVM
treatment and we expected a similar effect of ivermectin on the
viability of both nodules and adult worms. However, our results
showed significant differences between the good and poor response
Table 7. Reproductive status of female worms from multiply treated subjects, 90 days after ivermectin.
Female worm
age group
No. worms
embryogrammed Stretched microfilariae
Total stretched microfilaria Live stretched mf (active)
Mean/ worm Range % degenerate Mean/worm Range
Older aged 95 2829.0 0–14080 84.5% 437 0–6400
Middle aged 65 3141.3{ 0–13440 70.4% 930.6{ 0–8960
Young 20 1874.2 0–12800 80.5% 365.7 0–5120
Reproductive status of multiple IVM treated female worms 90 days after the second ivermectin treatment during the study; showing mean microfilarial numbers of total
and active (live) stretched microfilariae by age of female worm. The middle aged worms had a significantly higher ({ p#0.05) number of microfilariae in the uterus than
the young worms. Also the middle aged worms had a significantly higher ({ p# 0.05) number of live stretched mf than both young and older worms.
doi:10.1371/journal.pntd.0000998.t007
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of nodules were calcified and contained a mean of 0.35 female and
0.16 male worms per nodule (Table 4). On the other hand the
average numbers of male and female adult worms per nodule in
the poor response communities were similar to those in the pre-
study IVM-naı ¨ve community. In view of the fact that there were
few young worms which could suggest recent infection, this result
suggests a non response or resistance to multiple doses of IVM.
The proportions of older (62–78%) and middle aged worms
(22–30%) in all three community response categories were
similar. There were only 5% and 8% of young worms in the
poor and intermediate response communities, respectively, and
none in the good response communities. Additionally, the most
reproductively active group was the middle aged worms followed
by the older and then the young female worms. We conclude that
the major contributors to the skin mf population are not the
young adult worms. They must of necessity be the worms that are
a few to many years older than the young worms. Since these are
the worms that must have been exposed to multiple treatments
with IVM in their lifetime (and two IVM treatments during the
study itself) they represent non responders or worms that are
resistant to the suppressive effects of multiple doses of IVM on mf
production. However, the high proportion of degenerate
stretched mf in utero found in all communities indicates the
retention of the ability of IVM to prevent the release of the mf in
some worms.
It has been suggested [32,33], that an alternative explanation
for the high skin microfilarial repopulation rates is the occurrence
of repeated re-infections due to poor coverage in the study
communities and in surrounding communities. However, all of the
communities categorized as poor or intermediate responders had
good records of treatment coverage. While treatment coverage in
some communities in the East Gonja district (where the pre-study
treatment naı ¨ve community is found) may have been poor,
coverage in surrounding communities in the Atebubu and
Kintempo districts was generally good (Osei-Atweneboana and
Prichard, unpublished). The mechanism underlying the alternate
hypothesis must be the recruitment of significant numbers of new
adult worms that would account for the skin mf load. Notably, the
embryogrammes from the multi-dosed communities showed a
dearth of young adult worms at a modest level of reproductive
activity. These findings do not support the alternative hypothesis,
nor does the analysis of the annual transmission rate that would be
required to account for the skin mf repopulation rates observed in
the poor responder communities [31]. However, support for the
alternate hypothesis can be found in the pre-study IVM-naı ¨ve
community where coverage was poor and where there were a
relatively high proportion of young adult female worms (21%) as
compared to 5% in the poor responding communities. It is also of
interest that in this example of poor coverage in the treatment
naı ¨ve community, the recovery rate of skin mf count 364 days after
IVM treatment was only 41.6% of pre-treatment mf count, in
contrast to the situation seen in the poor responder communities
where the recovery rates were all well in excess of 100% of pre-
treatment mf counts.
The evidence from the initial and follow up studies enable a
description of the non response or resistance phenotype to multiple
treatment with IVM as follows: a) the microfilaricidal response is
normal, b) there is early skin microfilarial repopulation, high
microfilarial recovery rates one year post ivermectin treatment and
many subjects with more than 10 mf/snip, and c) many live
microfilariae are present in utero in female worms recovered 90
days after treatment. The discovery of such a phenotype should
lead to a reevaluation of control strategies in order to prevent the
spread of the phenomenon, and a search for the genotypic
correlate that would unequivocally confirm the development of
resistance.
From our studies and evidence from other studies [13,14,34],
we propose differing patterns of adult female O. volvulus
responses to repeated rounds of ivermectin treatment. The
Figure 2. Response profiles of microfilaria and female O. volvulus to repeated exposure to ivermectin.
doi:10.1371/journal.pntd.0000998.g002
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incomplete response, and non-responsive. The fully responsive is
manifested as female worms showing complete cessation of
embryogenesis leading to amicrofilaridermia for prolonged
periods; any microfilariae detected in a subject harboring only
such parasites must originate from an external source (e.g.
migration of infected individuals into the community). These
parasites fall into ‘‘category 1’’. The second response pattern is
the partial or incomplete response. This involves incomplete
cessation of embryogenesis in some female worms, resulting in
intermittent low level microfilariadermias beginning six or more
months after IVM treatment. These parasites fall into ‘‘category
2’’. The third response pattern, non-responders, shows minimal
interruption in embryogenesis with active intra-uterine mf
production associated with rapid repopulation of skin and high
recovery rates (‘‘category 3’’ responders). Of these, a subgroup
(category 3a in Figure 2) retained the ability to sequestrate mf in
utero. Because of this effect, skin mf do not rise precipitously
and abnormal levels of repopulation are only detected three or
more months after treatment. The embryogramme shows high
levels of microfilarial production associated with the accumula-
tion of a high proportion of degenerate intrauterine mf. In
category 3b, a high level of mf production is associated with a
low proportion of degenerate intra-uterine mf because the block
to their release has been lost and the ivermectin effect is reduced
to being only a microfilaricide. There are massive increases in
the skin mf soon after one month post-treatment (Awadzi,
unpublished). Category 3 responses are likely to allow for
parasite transmission for much of the year following ivermectin
treatment. It is possible that all of these patterns of response may
occur in different communities and the community response
category is determined by the proportional distribution of the
various adult worm response patterns. The proposed patterns of
O. volvulus response have been summarized in Figure 2. It is
likely that the mechanism of microfilaricidal action of IVM is
distinct and separable from the inhibition of the release of mf
from the uterus and the suppressive effects of ivermectin on the
adult female worm.
At the moment the prevalence of functional blindness, as
described by Kennedy and other [30], is almost absent in the
study communities, except for a few blind older members of the
communities. However, since the risk of developing ocular lesions
and blindness is directly related to the intensity of infection
[35,36] it is important to establish strict monitoring of
onchocerciasis pathology. Unfortunately, due to a lack of
monitoring, the extent of the non response of the adult female
worms and the influence it may have on the control of
onchocerciasis in areas subjected to annual treatments are at
present unknown.
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